InvestorsHub Logo
Followers 7
Posts 1577
Boards Moderated 0
Alias Born 02/27/2014

Re: learning curve post# 74767

Monday, 04/20/2015 9:10:11 AM

Monday, April 20, 2015 9:10:11 AM

Post# of 80868
The stock will get past the $6 soon and then it will be uplisted to Nasdaq.

I agree the current set of shareholders are not particularly knowledgeable about long term investing....and Musclepharm has been sending some mixed messages to these short term kind of investors, which has created excessive fluctuations in stock price.

It wasn't pretty that Musclepharm burned through $8 million credit line by buying stocks for $2.5 million, close another credit line of $2.5 million....making a burn for operations of $3 million appear like $8 million. Unsophisticated investors get scared even if not so bad.

Improvement from Q4 to Q1 was told to us implicitly during conference call....but no questions were answered because of investigation against company. Musclepharm didn't tell us that it would answer questions during next conference call....but made it clear, no questions were welcome. Unsophisticated investors get scared even if not so bad.

Right now, Musclepharm clearly got some better numbers to present us for Q1 or it got some solution coming, as it knows the consequences of posting negative results.

Still, unsophisticated investors are worried.

Nothing to worry about, Musclepharm is the next generation supplement company.

The endorsers are not bad, the products are not bad, the manufacturing is not bad....the communication flawed at times and panicking....with pictures from test marketing gas stations being posted on a daily basis, making unsophisticated investors believe that the company got no sales, when it got a wall at GNC and some damn good product positioning at Costco....and always overall good sales at bodybuilding.com.


Muscle Milk was endorsed by Aaron Hernandez....but the communication department at Cytosport was effective at killing the news....I wish Musclepharm had such a communication department.